Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab
Virtual Reality-Integrated Limb Propulsion Visual Feedback System for End-Effector Robot-Assisted Stroke Rehabilitation
1 other identifier
interventional
30
1 country
1
Brief Summary
This study evaluates a novel Virtual Reality (VR)-integrated visual feedback system designed to enhance limb propulsion during robot-assisted gait rehabilitation in individuals post-stroke. In collaboration with CUREXO, a rehabilitation robotics company, the system is embedded within the Morning Walk® end-effector robot and provides real-time visual feedback to facilitate symmetrical use of the paretic and non-paretic limbs. The goal is to address gait asymmetry commonly observed in hemiparetic stroke survivors by promoting improved paretic leg propulsion, which is a key contributor to forward movement during walking. A total of 30 participants (15 stroke, 15 healthy controls) aged 20 years or older will undergo single-session gait training using the VR-robot system. Participants will be assessed using spatiotemporal gait parameters, muscle activity, foot pressure, and vertical ground reaction forces. Additional safety measures-including a saddle-type weight support and real-time heart rate monitoring via smartwatch-are implemented to ensure a safe and controlled training environment. This study aims to test the feasibility and effectiveness of this VR-based system in improving gait symmetry and functional walking capacity in people recovering from stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2025
CompletedStudy Start
First participant enrolled
July 25, 2025
CompletedFirst Posted
Study publicly available on registry
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
April 1, 2026
March 1, 2026
1.4 years
July 9, 2025
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Spatiotemporal Gait Symmetry using the Zeno Walkway GaitMat
Spatiotemporal gait parameters will be collected using the Zeno Walkway GaitMat before and after a single session of VR-based gait training. Gait spatiotemporal parameters will be calculated from the ratio of step lengths (paretic/non-paretic in stroke group; left/right in healthy group). The step length will be compared pre- and post-training.
Baseline (pre-training) and immediately post-training (same session)
Secondary Outcomes (2)
Change in Peak Propulsive Force (Paretic vs. Non-Paretic Limb)
Baseline and immediately post-training (same session)
Change in Lower Extremity Muscle Activity
Baseline and immediately post-training (same session)
Study Arms (2)
Post-Stroke Group
EXPERIMENTALIndividuals who have had a stroke will complete a single session of VR-integrated gait training using the Morning Walk® end-effector robot. Gait performance will be evaluated before and after training.
Healthy Group
EXPERIMENTALHealthy participants will undergo the same single-session VR-integrated gait training using the Morning Walk® end-effector robot. Pre- and post-training assessments will be conducted.
Interventions
A single-session gait training protocol using the Morning Walk® end-effector robot with real-time virtual reality visual feedback to encourage paretic limb propulsion and symmetrical gait. This intervention is intended to study participants' behavioral and biomechanical responses to the VR feedback, not to evaluate the robot as a device.
Eligibility Criteria
You may qualify if:
- Adults aged 20 years or older.
- For post-stroke participants:
- Diagnosis of stroke at least 1 month prior to participation.
- Able to walk at least 10 meters with or without assistive devices.
- For healthy participants:
- ° Must walk independently without assistive devices.
You may not qualify if:
- Individuals with a life expectancy of less than one year.
- Comatose individuals.
- Individuals unable to follow three-step commands.
- Individuals with lower limb amputation.
- Individuals with poorly controlled diabetes (e.g., foot ulceration).
- Individuals with legal blindness.
- Individuals with progressive neurological conditions.
- Medically unstable individuals.
- Individuals with significant musculoskeletal impairments.
- Individuals with congestive heart failure or unstable angina.
- Individuals with peripheral vascular disease.
- Individuals with severe neuropsychiatric disorders (e.g., dementia, cognitive deficits, or severe depression).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas Medical Branch
Galveston, Texas, 77555, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2025
First Posted
July 28, 2025
Study Start
July 25, 2025
Primary Completion (Estimated)
December 27, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share